Vifor
- Business Wire
VFMCRP announces positive results of phase-III clinical trial of Velphoro® in China
Met primary efficacy endpoint of non-inferiority versus sevelamer carbonate Velphoro® effective in lowering and maintaining serum phosphorus level Safety profile…
Read More » - Business
Vifor Pharma to propose Dr Alexandre LeBeaut as Board member
St. Gallen, Switzerland: Dr Alexandre LeBeaut to be proposed to Annual General Meeting for appointment to Board Dr Gianni Zampieri…
Read More »